Lomo, Arriana .
HRN: 24-23-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/08/2025
03/15/2025
IV
200mg
Q6
Urti
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes